Manorama Industries (541974) Q4 18/19 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 18/19 earnings summary
22 Oct, 2026Executive summary
FY18-19 focused on specialty fats and butters manufacturing after trading operations were discontinued; manufacturing revenue rose while reported total revenue fell against a prior year that included substantial trading sales.
Profitability improved, supported by manufacturing growth and operational efficiency; a new integrated plant was under construction to address demand exceeding current supply.
Financial highlights
Manufacturing revenue was ₹101.77 crore vs ₹61.22 crore in FY17-18; trading revenue was nil vs ₹157.91 crore, and total revenue was ₹106.06 crore vs ₹220.93 crore.
Manufacturing EBITDA was ₹31.86 crore vs ₹19.33 crore; PAT was ₹19.06 crore vs ₹9.93 crore.
Manufacturing operating profit was ₹22.77 crore vs ₹14.69 crore; profit before tax was ₹25.95 crore vs ₹16.37 crore.
Operating cash flow was negative ₹9.20 crore, while cash and cash equivalents ended FY18-19 at ₹495.31 crore.
Outlook and guidance
FY19-20 and beyond: management expected healthy top- and bottom-line growth and market-share gains, citing a strong order pipeline and export traction.
The integrated Birkoni plant was expected to add 15,000 MT p.a.; the first phase was expected to be operational by November 2019, with seed milling expected from December 2019.
CBE production was expected to reach 18,000 MT by 2021 as expanded capacity supports demand across food, confectionery and cosmetics markets.
Latest events from Manorama Industries
- Strong Q2/H1 growth and exports support phased expansion despite margin and cash-flow pressures.541974
Q2 26/27 - FY23 growth accelerated as capacity expanded, despite input-cost and execution pressures.541974
Q4 22/23 - Revenue rose 37.8% and PAT 65.6% as expansion targets global specialty-fat demand.541974
Q4 21/22 - FY20 sales rose 84% as a new plant expanded capacity amid pandemic disruption.541974
Q4 19/20 - Revenue advanced, but pandemic pressure cut profit as capacity expansion continued.541974
Q4 20/21 - Q1 FY27 revenue and profit surged, supported by global expansion, capex, and strong margins.541974
Q1 26/27 - Revenue up 76.1%, EBITDA up 92.5%, and major CapEx and expansion plans approved.541974
Q4 25/26 - Record Q3 FY25 revenue and profit, strong margins, and global expansion with new subsidiaries.541974
Q3 24/25 - H1 FY26 revenue and profit surged YoY, margins remained strong, and FY26 guidance was upgraded.541974
Q2 25/26